Phase II randomized, placebo-controlled trial of phytotherapeutic product Catuama for breast cancer women undergoing adjuvant radiation therapy.

医学 安慰剂 乳腺癌 医院焦虑抑郁量表 内科学 随机对照试验 生活质量(医疗保健) 癌症 不利影响 萧条(经济学) 外科 焦虑 精神科 病理 护理部 经济 替代医学 宏观经济学
作者
Felipe Melo Cruz,Daniel de Iracema Gomes Cubero,Patrícia Xavier Santi,Luciana Garcia Landeiro,Andressa Sayuri Tamashiro,Larisse Soares Ribeiro,Auro del Giglio
出处
期刊:Journal of Clinical Oncology [American Society of Clinical Oncology]
卷期号:31 (15_suppl): e20524-e20524
标识
DOI:10.1200/jco.2013.31.15_suppl.e20524
摘要

e20524 Background: Fatigue and Depression are common in patients undergoing Breast Cancer (BC) treatment. Catuama is a registered phytotherapic that contains 4 brazilian herbs per capsule: Trichilia catigua (87.5mg), Ptychopetalum olacoides (87.5mg), Paullinia cupana (125 mg) and Zingiber officinale (10mg). Objectives: Since one of its constituents is Guarana (Paulinia cupana) which we already reported to have anti-fatigue effects, we decided to test Catuama potential anti-fatigue effects in BC women undergoing adjuvant 4 weeks of Radiation Therapy (RxT). Methods: This is a double blinded, randomized, placebo-controlled, Phase II cross-over trial. Patients with histologically proven BC with the indication of adjuvant RxT, non-pregnant nor breastfeeding, older than 18 years of age, with ECOG PS 0 or 1, without a history of cardiac, renal, hepatic or psychiatric decompensation, received Catuama 1 capsule twice daily versus a matching placebo for the first 2 weeks of RxT treatment, followed by a week of wash out, followed by an additional two weeks of treatment with crossover of experimental arms. Patients were evaluated on days 1, 15 and 36 with the Brief Fatigue Inventory (BFI), Hospital Anxiety and Depression Scale (HADS), Quality of Life FACIT-F, FACIT-ES questionnaires, and Chalder Fatigue scale. Results: We enrolled 90 patients with a median age of 53 years (26 – 80). We saw no statistically significant differences of FACIT ES, FACIT F, HADS, Chalder or BFI scores treated with Catuama or Placebo when we considered all included patients. When we selected only patients with a BFI score above 30, Catuama significantly decreased BFI scores as compared to baseline (p<0.0001). We observed one instance of grade 3 hypermagnesemia in the Catuama arm and one patient had hyperglicemia grade 3 both in the Catuama and in the placebo arm. No grade 4 toxicities were seen. Conclusions: Catuama may help selected patients who already start RxT with evidence of fatigue.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
又发了NSC发布了新的文献求助10
1秒前
4秒前
852应助hai采纳,获得10
5秒前
Jasper应助Rn采纳,获得10
5秒前
lico完成签到,获得积分10
6秒前
yn完成签到 ,获得积分10
6秒前
7秒前
CipherSage应助真实的一鸣采纳,获得10
7秒前
vikey完成签到 ,获得积分10
8秒前
研友_VZG7GZ应助popcorn采纳,获得30
9秒前
9秒前
10秒前
打死小胖纸完成签到,获得积分10
10秒前
小米辣发布了新的文献求助10
11秒前
PIEZO2发布了新的文献求助10
12秒前
12秒前
卡皮巴拉发布了新的文献求助10
17秒前
Hui发布了新的文献求助10
17秒前
17秒前
小马甲应助科研通管家采纳,获得10
17秒前
彭于晏应助科研通管家采纳,获得10
17秒前
上官若男应助科研通管家采纳,获得10
17秒前
18秒前
不配.应助科研通管家采纳,获得10
18秒前
英姑应助科研通管家采纳,获得10
18秒前
慕青应助科研通管家采纳,获得10
18秒前
科研通AI2S应助科研通管家采纳,获得10
18秒前
zack应助科研通管家采纳,获得30
18秒前
18秒前
杳鸢应助科研通管家采纳,获得10
18秒前
李爱国应助科研通管家采纳,获得10
18秒前
英姑应助科研通管家采纳,获得10
18秒前
科研通AI2S应助科研通管家采纳,获得10
18秒前
杳鸢应助科研通管家采纳,获得10
18秒前
20秒前
20秒前
21秒前
善学以致用应助xiaofenzi采纳,获得10
22秒前
24秒前
25秒前
高分求助中
Spray / Wall-interaction Modelling by Dimensionless Data Analysis 2000
Evolution 3rd edition 1500
保险藏宝图 1000
Lire en communiste 1000
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 700
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 700
Mathematics and Finite Element Discretizations of Incompressible Navier—Stokes Flows 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3185724
求助须知:如何正确求助?哪些是违规求助? 2835978
关于积分的说明 8007258
捐赠科研通 2498506
什么是DOI,文献DOI怎么找? 1333515
科研通“疑难数据库(出版商)”最低求助积分说明 636868
邀请新用户注册赠送积分活动 604637